CRYO CELL INTERNATIONAL INC
For the period ended Nov 30, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on signature page)
POWER OFATTORNEY
Each of the undersigned officers and directors of Cryo-Cell International, Inc., hereby constitutes and appoints David Portnoy, Mark Portnoy and Jill Taymans, each their true and lawful attorneys-in-fact and agents, for them and in their name, place and stead, in any and all capacities, to sign their names to any and all amendments to this Report on Form 10-K, and other related documents, and to cause the same to be filed with the Securities and Exchange Commission, granting unto said attorneys, full power and authority to do and perform any act and thing necessary and proper to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present, and the undersigned for himself or herself hereby ratifies and confirms all that said attorney shall lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| SIGNATURE | TITLE | DATE |
|---|---|---|
| /s/ David Portnoy | Chairman of the Board and | |
| David Portnoy | Co-Chief Executive Officer | |
| (principal executive officer) | February 27, 2026 | |
| /s/ Mark Portnoy | Co-Chief Executive Officer | February 27, 2026 |
| Mark Portnoy | ||
| /s/ Jill Taymans | Chief Financial Officer | |
| Jill Taymans | (principal financial and accounting officer) | February 27, 2026 |
| /s/ Harold Berger | Director | February 27, 2026 |
| Harold Berger | ||
| /s/ Daniel Mizrahi | Director | February 27, 2026 |
| Daniel Mizrahi | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.